Omega Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Omega Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q2 2024.
Omega Therapeutics, Inc. Assets for the quarter ending June 30, 2024 was $168M, a 26.5% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$168M	-$60.8M	-26.5%	Jun 30, 2024	10-Q	2024-08-06
Q1 2024	$184M	+$27.4M	+17.5%	Mar 31, 2024	10-Q	2024-05-06
Q4 2023	$204M	+$58.4M	+40%	Dec 31, 2023	10-Q	2024-08-06
Q3 2023	$218M	+$47.7M	+28.1%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$229M	+$36M	+18.6%	Jun 30, 2023	10-Q	2023-08-03
Q1 2023	$156M	-$61M	-28.1%	Mar 31, 2023	10-Q	2023-05-04
Q4 2022	$146M	-$87.3M	-37.4%	Dec 31, 2022	10-K	2024-03-28
Q3 2022	$170M	-$73.2M	-30.1%	Sep 30, 2022	10-Q	2022-11-08
Q2 2022	$193M	+$63M	+48.4%	Jun 30, 2022	10-Q	2022-08-04
Q1 2022	$217M			Mar 31, 2022	10-Q	2022-05-04
Q4 2021	$233M	+$205M	+731%	Dec 31, 2021	10-K	2023-03-01
Q3 2021	$243M			Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$130M			Jun 30, 2021	10-Q	2021-09-10
Q4 2020	$28.1M			Dec 31, 2020	10-K	2022-03-10

* An asterisk sign (*) next to the value indicates that the value is likely invalid.